Keyword summary
88%58 analyzed articles/videos8,548 analyzed words
BS Summary: These Stat results contain 48 faulty reasoning types, including Biased Writer Voice, Negativity Bias, and Attempt to Sell a Product or Service, with Framing Effect as the most egregious example at 17.4% saturation with 6,335 hits. Analysis detected 42,157 faulty-reasoning hits from 36,470 analyzed words across 58 articles, generating a BS Score of 2.4% and a BS Rank of 51% (29,251 of 59,378 keywords). This Stat is worse (more manipulative) than 50.70% of the peer group.
Stat
Keyword ranking list
PercentileKeywordBS Score
0%Property Transfers1%
0%Madison Township1%
0%Buc-Ee's Travel Center1%
0%Buc Ees Travel Center1%
0%Paul Demark1%
51%Stat (selected)3%
100%Rad Power Bikes60%
100%Mike Lewis60%
100%Joni Balter60%
100%Lawrence O'donnell69%
100%Bondi Beach Shooting70%

Ranking context

Position among analyzed keywords

51% percentile
025507510050.7% percentile
2.4% BS Score58 analyzed articles36.5K analyzed words

Reasoning profile

Selected profile versus the sitewide rate

KeywordSitewideShared scale 0–50%
0.0%10%20%30%40%50%Appeal to EmotionSitewide 15.9%Keyword 5.5%5.5%Framing EffectSitewide 26.9%Keyword 17.4%17.4%Attempt to Sell a Product…Sitewide 0.5%Keyword 8.5%8.5%Biased Writer VoiceSitewide 5.3%Keyword 12.8%12.8%Negativity BiasSitewide 19.2%Keyword 12.0%12.0%In-Group BiasSitewide 6.9%Keyword 0.7%0.7%Appeal to AuthoritySitewide 11.1%Keyword 5.1%5.1%Halo EffectSitewide 6.7%Keyword 1.4%1.4%Availability HeuristicSitewide 9.1%Keyword 4.0%4.0%AnecdotalSitewide 5.2%Keyword 1.6%1.6%

Sitewide departure map

Above the diagonal means this profile uses the pattern more often

0.0%0.0%10%10%20%20%30%30%40%40%50%50%Framing Effect: Keyword 17.4%, sitewide 26.9%Negativity Bias: Keyword 12.0%, sitewide 19.2%Appeal to Emotion: Keyword 5.5%, sitewide 15.9%Biased Writer Voice: Keyword 12.8%, sitewide 5.3%Appeal to Authority: Keyword 5.1%, sitewide 11.1%Availability Heuristic: Keyword 4.0%, sitewide 9.1%Attempt to Sell a Product or Service: Keyword 8.5%, sitewide 0.5%Hasty Generalization: Keyword 7.5%, sitewide 8.1%Confirmation Bias: Keyword 4.7%, sitewide 7.5%In-Group Bias: Keyword 0.7%, sitewide 6.9%Halo Effect: Keyword 1.4%, sitewide 6.7%Optimism Bias: Keyword 6.1%, sitewide 6.0%Anecdotal: Keyword 1.6%, sitewide 5.2%Overconfidence Bias: Keyword 1.1%, sitewide 4.6%Anchoring Bias: Keyword 1.3%, sitewide 4.0%Self-Serving Bias: Keyword 0.8%, sitewide 3.7%Post Hoc (False Cause): Keyword 2.0%, sitewide 3.3%Out-Group Homogeneity Bias: Keyword 0.2%, sitewide 3.1%Fundamental Attribution Error: Keyword 0.8%, sitewide 2.7%Ambiguity (Equivocation): Keyword 2.7%, sitewide 0.8%Recency Bias: Keyword 1.8%, sitewide 2.7%Unattributed Quote: Keyword 2.6%, sitewide 1.1%Loss Aversion: Keyword 1.4%, sitewide 2.5%Bandwagon: Keyword 0.7%, sitewide 2.2%Framing EffectSitewide rateKeyword rate

Analyzed articles and videos

NIH plans to block international researchers on visas from accessing key funding avenue40%
STAT62%By Anil Oza43%8/7/2026, 9:31:41 AM
He grew up near Boston, went to Harvard, and worked at MIT. Why did he found his startup in California?83%
STAT62%By Emma Platoff — Boston Globe96%8/7/2026, 1:30:00 AM
FDA approves Replimune melanoma drug previously rejected twice73%
STAT62%By Elaine Chen61%8/6/2026, 12:59:28 PM
Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts45%
STAT62%By Ed Silverman73%8/6/2026, 12:00:00 PM
Medicare pushes ACCESS but doesn’t tell patients what providers offer it3%
STAT62%By Mario Aguilar34%8/6/2026, 5:54:43 AM
FDA approves Takeda’s narcolepsy drug, a boon for new class of treatments72%
STAT62%By Elaine Chen61%8/5/2026, 1:41:35 PM
Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI34%
STAT62%By Mario Aguilar34%8/5/2026, 1:05:08 PM
Exemption of rare disease therapies in drug-pricing pilots would wipe out huge savings, analysis finds53%
STAT62%By John Wilkerson76%8/5/2026, 1:30:00 AM
California Supreme Court sides with Gilead in ‘duty’ to innovate case76%
STAT62%By Ed Silverman73%8/3/2026, 1:56:25 PM
Eli Lilly to allow more patients to apply for special access to unapproved obesity drug51%
STAT62%By Lizzy Lawrence85% Elaine Chen61%8/3/2026, 10:27:38 AM